Cyrus Arman to captain CytoDyn, leronlimab, through troubled waters
Cyrus Arman to captain CytoDyn, leronlimab, through troubled waters Published: Jul 14, 2022 By Alex Keown BioSpace Beset by clinical holds and the
Cyrus Arman to captain CytoDyn, leronlimab, through troubled waters Published: Jul 14, 2022 By Alex Keown BioSpace Beset by clinical holds and the
Feb. 28, 2022 – Comments made in a video interview by CytoDyn Inc.’s former president and CEO suggesting that the investigational new drug (IND)
Todos Medical (OTCMKTS: TOMDF) and CytoDyn Inc. (OTCMKTS: CYDY) might be looking at a pretty good week ahead of them. On Friday a scathing
If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16
If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16
If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16
If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16
A California mother of three has survived COVID-19 after being given an experimental drug called “leronlimab.” Fifty-five-year-old Samantha
New visualisation of the COVID-19 virus. Photo by Fusion Medical Animation on Unsplash Montefiore Health System and Albert Einstein College of
New visualisation of the COVID-19 virus. Photo by Fusion Medical Animation on Unsplash Montefiore Health System and Albert Einstein College of
CytoDyn Inc (OTCMKTS:CYDY) has emerged as one of the biggest runners in small caps in recent months exploding up from $0.261 lows back in December to
CytoDyn Inc (OTCMKTS:CYDY) is skyrocketing up the charts almost doubling on Monday alone and trading over $100 million in dollar volume – in 1 day
Data: Covid-19 testing in the United States There’s been a lot of good news last week, and I tweeted some of it. A lot of private sector companies
CytoDyn Inc (OTCMKTS:CYDY) has established a new base over the $1 mark in recent trading and speculators are looking for another leg up. CYDY popped
Catch up on funding news from April involving technology companies based in Washington state:—Pattern Computer, a Redmond-based startup developing